MedPath

Effectiveness of stepped care guided self-help followed by face-to-face cognitive behavioral therapy versus standalone internet-delivered or face-to-face cognitive behavioral therapy for anxiety

Not Applicable
Conditions
Treatment and prevention of anxiety symptoms in mental health services
Mental and Behavioural Disorders
Registration Number
ISRCTN10064801
Lead Sponsor
Helsinki University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
948
Inclusion Criteria

1.Minimum age of 16 years2.Suitable for step 1-2 treatments (guided self-help, iCBT or CBT intervention) for anxiety in the first assessment3.GAD-7 =5

Exclusion Criteria

General exclusion criteria for step 1-2 treatments (i.e. recommended stepping up):1. Serious suicidal thoughts, plans or any self-harming act or suicidal attempt within the past 2 months2. Ongoing other psychological treatment for depression and/or anxiety3. Cognitive impairment4. Inability to speak, read and write Finnish5. Currently symptomatic psychotic illness or bipolar disorder6. Drug or alcohol dependence

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anxiety symptoms measured by the GAD-7. The GAD-7 is administered weekly from the beginning of the intervention for 16 weeks and at follow-up time points (e.g. 4, 6, 8, and 12 months as well as 2, 5, 10, 15 and 20 years) to enable ITT (intention to treat) -analysis and modeling the symptom change in time.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath